Candel Therapeutics CEO Paul Peter Tak disposes of common shares worth $3,164,815.85
CADL•CEO share disposal and option exercise
Candel Therapeutics CEO Paul Peter Tak disposes of common shares worth $3,164,815.85
- Paul Peter Tak, Chief Executive Officer, cut his direct stake in Candel Therapeutics to 113,321 shares.
- Disposed of 280,245 shares on Sep. 10-11 at weighted average prices of $11.5 and $10.46.
- Exercised options for 125,000 shares at $1.55 on Sep. 10.
